Receiving a Term Sheet from a venture capital firm is an exciting milestone, but the economic and control provisions contained within can permanently alter your startup’s trajectory. A Term Sheet outlines the primary terms of an investment, which eventually dictate the binding Shareholders' and Share Subscription Agreements. Acclevate provides expert, Big-4 level review and negotiation advisory, helping founders decode complex investment terms and maintain operational control.
Serving as the blueprint for angel or venture capital funding, a Term Sheet outlines key investment parameters such as pre-money valuation, investment amounts, liquidation preferences, and anti-dilution provisions. It establishes a mutual understanding of investment terms, enabling smooth drafting of definitive agreements while legally locking in essential terms like exclusivity, confidentiality, and due diligence timelines. It ensures that founders and investors are aligned on control, governance, and economics before incurring extensive legal fees.
Founders often focus solely on the pre-money valuation, ignoring underlying economic terms that can completely undermine a high headline figure. Acclevate reviews critical clauses such as liquidation preferences (participating vs non-participating), anti-dilution provisions (weighted average vs full ratchet), and option pool expansions, ensuring you do not suffer excessive dilution in downstream funding rounds.
Venture investors typically demand board seats and veto powers over major corporate actions (protective provisions). We assist founders in negotiating board composition, reserving operational decisions for management, and keeping veto thresholds reasonable, ensuring you retain the flexibility required to rapidly pivot and scale your software business.
Establishes pre-money valuation, investment size, and post-money cap table layouts to prevent equity dilution surprises.
Defines the priority of payouts to investors in exit or liquidation events, establishing the financial risk-reward profile of the deal.
Legally binds the startup to stop seeking other investors during a set due diligence window, fostering trust and transaction momentum.
Establishes initial guidelines for future board composition, observer seats, and protective voting thresholds for investor approval.
The majority of a term sheet—such as valuation, investment size, board seats, and share rights—is non-binding and serves as a framework for negotiation. However, sections governing exclusivity, confidentiality, expenses, and governing law are explicitly drafted as legally binding commitments.
Liquidation preference determines the order of payouts during a liquidity event (like an acquisition or winding up). A 1x non-participating preference ensures investors get their original investment back before common shareholders receive any exit proceeds, protecting their downside risk.
The exclusivity or 'no-shop' clause typically lasts between 30 to 60 days. This legally restricts the founders from soliciting or negotiating funding deals with other investors while the current investor conducts detailed financial, legal, and technical due diligence.
Comprehensive solutions tailored perfectly to your industry.
Secures international brand protection in up to 132 countries through a centralized Madrid Protocol filing.
